ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Discover Why Ashwagandha Can Be Used for Stress and Anxiety

How Can You Benefit From Vitamin B12?

Calorie restriction promotes longevity through effects on mitochondrial network

Lower magnesium levels linked with increased mortality risk during up to 40 years of follow-up

Higher resveratrol dose linked to lower glucose levels in type 2 diabetics

What Is Bitter Orange?

Black Tea Is Great for Your Gut

Drug can dramatically reduce weight of people with obesity

Tryptophan's Possible Effects for Your Health

New Finding: Broccoli Helps Heal Leaky Gut

 
Print Page
Email Article

Loss of Smell Linked to Key Protein in Alzheimer’s Disease, New Penn Study Shows

  [ 139 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 18, 2004


First signal of disease could provide future test for early stages of neurodegenerative illnesses (Philadelphia, PA) -

Researchers at the University of Pennsylvania School of Medicine have linked smell loss in mice with excessive levels of a key protein associated with Alzheimer’s and Parkinson’s disease. Smell loss is well documented as one of the early and first clinical signs of such diseases. If smell function declines as the levels of this protein increase in brain regions associated with smelling, the research could validate the use of smell tests for diagnosing Alzheimer’s disease.

Their findings appear in the March 12th issue of the journal Brain Research, the commemorative volume 1000. “The loss of smell - or olfactory dysfunction - has been known for more than a decade as an early sign of several neurodegenerative diseases, but we have never been able to link it to a pathological entity that is measurable over time,” said Richard Doty, PhD, Professor and Director of Penn’s Smell and Taste Center, who is also the team leader of the study. “By tying decrements in the ability to smell to the presence of key disease proteins, such as tau, we may well be able to assess the degree of progression of selected elements of Alzheimer’s disease and related disorders by scores on quantitative smell tests.”

A total of ten mice were evaluated in this experiment - five mice that were genetically engineered to be a model for human Alzheimer’s and Parkinson’s disease, and five normal control mice that do not overexpress tau proteins. Olfactory dysfunction was evaluated by measuring the amount of time the mice spent investigating unfamiliar odors, such as peppermint or vanillin.

Unlike normal mice, those with smell deficits do not spend much time investigating such odors, and do not show a preference for “novel” odors over “familiar” odors. The results of the Penn study showed that only the control mice, with no excess of tau proteins, expressed an interest in new odors, indicating a normal sense of smell. The mice that had excess in tau protein showed little or no interest in such odors, implying olfactory dysfunction.

Analysis of brain tissue from the diseased mice confirmed a link between the olfactory loss and the presence of excess tau proteins in brain structures important for smelling. Additionally, the genetically engineered mice exhibited a significant amount of neurofibrillary tangles, structures also linked to Alzheimer’s disease.

No test currently exists for the detection of Alzheimer’s disease. A definitive diagnosis is only confirmed upon death when the brain tissue becomes available for testing of the presence of such proteins and other physiological markers of the disease. The process for diagnosis before death is less certain and involves several kinds of tests - for memory, problem solving, attention and counting - plus review of a patient’s complete medical history from a primary care physician, and possibly brain scans and consultations from other specialists.

With several diagnostic tools and criteria, physicians can make a diagnosis of moderate to severe stages of Alzheimer's disease with 90 percent accuracy. However, diagnosis is less certain for the early stages of the illness. No explanation exists for what causes the alterations in smell perception associated with neurodegenerative disorders. What is known is that key physiological markers for these illnesses - deposits of neurofibrillary tangles or amyloid plaques, Lewy bodies or tau and alpha-synuclein proteins - are commonly found in brain regions associated with the perception of odors in the bodies of people who suffer from these illnesses.

“The mice who overexpress tau, a protein associated with a family of neurological disorders that includes Alzheimer’s disease and Parkinson’s disease, have decreased ability to smell,” said Doty. “We next plan to study the progression of the disease entities in the brain as it relates to smell dysfunction. These experiments are part and parcel to better understanding the physical causes of such neurodegenerative diseases.”

About the Abramson Cancer Center: The Abramson Cancer Center of the University of Pennsylvania was established in 1973 as a center of excellence in cancer research, patient care, education and outreach. Today, the Abramson Cancer Center ranks as one of the nation’s best in cancer care, according to US News and World Report, and is one of the top five in National Cancer Institute (NCI) funding. It is one of only 39 NCI-designated comprehensive cancer centers in the United States. Home to one of the largest clinical and research programs in the world, the Abramson Cancer Center of the University of Pennsylvania has 275 active cancer researchers and 250 Penn physicians involved in cancer prevention, diagnosis and treatment. More information about the Abramson Cancer Center is available at: www.pennhealth.com/cancer.



Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Ultra EPA  - Fish Oil Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance
Astaxanthin - A Little-Known but Power-Packed Nutrient Astaxanthin - A Little-Known but Power-Packed Nutrient
Safely Burn Away Body Fat Safely Burn Away Body Fat
Prepare Yourself for Cold & Flu Season Prepare Yourself for Cold & Flu Season
The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map